Memorandum: Private Sector Engagement in the Joint Action Personalised Cancer Medicine Opportunities, Scope and Engagement Process for Private Sector Partners JA PCM is opening its doors to private sector engagement.
Slides JA PCM Private Sector: Contribution Briefing & Initial Discussion Find below the slide deck to the meeting that took place on 8 July 'JA PCM Private Sector: Contribution Briefing & Initial Discussion'.
Mapping the Adoption of Liquid Biopsy and Minimal Residual Disease Monitoring Across Europe This report, produced under JA PCM WP10 (Tertiary prevention), maps the implementation of Liquid Biopsy (LB) and Minimal Residual Disease (MRD) monito
Webinar Slides - Private Sector Engagement: Opportunities & Next Steps Catch Up: May 26 Webinar - Private Sector Engagement: Opportunities & Next StepsThe JA PCM consortium welcomed indust
Leaflet - Meet the EU Joint Action on Personalised Cancer Medicine Across Europe, cancer care is evolving - and JA PCM will help lead the way! Discover how in the new project's leaflet.
Press release - EU launches ambitious Joint Action on Personalised Cancer Medicine The JA PCM kick-off meeting took place in Brussels on 14-15 January 2026, marking the official launch of the European Joint Action on Perso
JA PCM kick off agenda and leaflet This online brochure presents the agenda of JA PCM kick off event, as well as the project as a whole.
